Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide as Adjunctive Therapy for Spontaneous Bacterial Peritonitis in Liver Cirrhosis
NCT07808450Phase 2Recruiting
- Sponsor
- Tanta University
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in spontaneous bacterial peritonitis (SBP), sponsored by Tanta University. Started Oct 2026; status: recruiting.
02
Drugs
nitazoxanide
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT07808450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07808450.